Anthony J. King

Anthony J. King

Auto-generated profile, based on publicly available information

Anthony J. King

Nottingham University Hospital, Nottingham, United Kingdom

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2001 in British Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
HDHarminder S Dua
Harminder S Dua
AKAnthony J King
Anthony J King
AJAnnie Joseph
Annie Joseph

1 December 2013 in Ophthalmology
Verified
Journal Article
Closed access
JKJames F. Kirwan
James F. Kirwan
ALAlastair J. Lockwood
Alastair J. Lockwood
PSPeter Shah
Peter Shah
AMAlex Macleod
Alex Macleod
DBDavid C. Broadway
David C. Broadway
PAPavi Agrawal
Pavi Agrawal

1 April 2006 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
GAG Ainsworth
G Ainsworth
ARA Rotchford
A Rotchford
HDH S Dua
H S Dua
AKA J King
A J King
To report a novel technique using amniotic membrane to cover exposed glaucoma tube shunts. A consecutive series of three cases that underwent drainage tube shunt surgery with the Ahmed valve for intractable glaucoma. All three patients developed exposure of the tube secondary to necrosis of the overlying bovine pericardial patch and conjunctiva. Repair of the defect was carried out with a double layer of amniotic membrane, the inner one acting as a graft and the outer as a patch. Autologous serum was used to promote epithelial growth. Successful lasting closure of the conjunctival defect was achieved in all cases. Erosion of the drainage tube following shunt surgery is a potentially serious problem. It can be successfully managed using a double layer of amniotic membrane.

1 March 2002 in Ophthalmology
Verified
Journal Article
Closed access
DSDilani Siriwardena
Dilani Siriwardena
PKPeng T Khaw
Peng T Khaw
AKAnthony J King
Anthony J King
MDMark L Donaldson
Mark L Donaldson
BOBarry M Overton
Barry M Overton
MCM Francesca Cordeiro
M Francesca Cordeiro

11 June 2013 in BMJ
Verified
Journal Article
Closed access
PDF file
AKAnthony King
Anthony King
AAAugusto Azuara-Blanco
Augusto Azuara-Blanco
ATAnja Tuulonen
Anja Tuulonen

24 June 2010 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
ARA. P. Rotchford
A. P. Rotchford
RJR. Jayasawal
R. Jayasawal
SMS. Madhusudhan
S. Madhusudhan
SHS. Ho
S. Ho
AKA. J. King
A. J. King
SVS. A. Vernon
S. A. Vernon
Purpose To investigate the effect of diode laser cyclophotocoagulation for glaucoma on central visual function in patients with good visual acuity (VA). Patients and methods Patients with preoperative VA 20/60 or better who had undergone cyclodiode treatment according to a standard protocol were evaluated retrospectively. The primary outcome variable was a recorded loss of two or more Snellen lines of best corrected VA during follow-up. Successful intraocular pressure (IOP) control was defined as being between 6 and 21 mmHg inclusive without oral acetazolamide or other glaucoma surgery. Results 49 eyes of 43 patients with a median pretreatment acuity of 20/30 were included (range 20/16–20/60). After a mean duration of follow-up of 5.0 years, median VA was 20/60 with a line loss of two or more recorded in 15 eyes (30.6%) (mean survival time 7.7 years). 67.3% (33/49) retained VA 20/60 or better, but VA deteriorated by one Snellen line or more in 31 (63.2%), and in 16.3% (8/49), final VA was <20/200. In cases experiencing a two-line loss in acuity, the main causes were glaucoma progression (nine cases) and macula oedema (four cases). Visual loss was unrelated to total treatment dose (mean 99.7 J), initial acuity or initial IOP level. IOP was controlled at final follow-up in 39/49 (79.6%) with no cases of hypotony. Conclusions Most of these eyes with difficult to manage glaucoma retained their good VA over long-term follow-up after undergoing diode laser cyclophotocoagulation. The proportion losing two Snellen lines is in line with that reported after trabeculectomy or tube surgery. These results suggest a possible role for the use of transscleral cyclodiode in selected eyes with significant visual potential. Further controlled prospective studies are required to better define this role.